SCHEMBL9053704

SCHEMBL9053704

C=C(C)CN1C(=O)C(C)(C)SC1=NN=C(NC)SSC(=NN=C1SC(C)(C)C(=O)N1CC(=C)C)NC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9054508 0.76 — —
SCHEMBL11812673 0.74 ALDH1A1 (0.30) —
SCHEMBL9152818 0.74 ALDH1A1 (0.30) —
SCHEMBL9495397 0.67 ALDH1A1 (0.32) —
SCHEMBL9495401 0.67 ALDH1A1 (0.32) —
SCHEMBL9492962 0.65 — —
SCHEMBL9053887 0.65 ALDH1A1 (0.39) —
SCHEMBL9492878 0.63 — —
SCHEMBL9053923 0.62 LMNA (0.48) —
SCHEMBL10383854 0.54 ALDH1A1 (0.41) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0508955-B1 Use of 2-iminothiazolidin-4-one derivatives as new medicaments CIBA GEIGY AG (CH) 1996-06-19 — — EP claimed
Send feedback